Literature DB >> 20834205

Evaluation of cardiac masses: the role of cardiovascular magnetic resonance.

Dipan J Shah1.   

Abstract

Evaluation of known or suspected cardiac masses is a frequent and expanding indication for referral to the cardiac magnetic resonance (CMR) laboratory. Most patients will have undergone an initial echocardiogram that raised the suspicion of an abnormality. However, echocardiography suffers from several well-described limitations: restricted field of view; incomplete assessment of an invading cardiac mass due to an unfavourable patient body habitus; and limited ability to perform tissue characterization. The role of CMR in this setting is well established because of its ability to obtain a wide field of view, generate high contrast and spatial resolution, and perform multiplanar imaging, allowing precise demonstration and localization of a mass. In clinical practice, CMR serves several useful purposes. First, it is able to help discriminate between a true cardiac mass and a pseudomass. Second, tissue characterization by CMR can assist in generating a differential diagnosis, and can distinguish a cardiac neoplasm (which generally will require excision) from other conditions, such as intracardiac thrombus, lipomatous hypertrophy or benign lipomas (all of which generally do not require excision). Third, even when the etiology of a mass is known, CMR can provide useful information as to the extent of invasion into cardiac, as well as extracardiac structures, and associated findings. This article provides a general overview as to how CMR may be clinically useful to the practicing cardiovascular specialist.

Entities:  

Mesh:

Year:  2010        PMID: 20834205     DOI: 10.14797/mdcj-6-3-4

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  3 in total

Review 1.  Ileal neuroendocrine tumors and heart: not only valvular consequences.

Authors:  Jan Calissendorff; Eva Maret; Anders Sundin; Henrik Falhammar
Journal:  Endocrine       Date:  2014-10-16       Impact factor: 3.633

2.  ⁶⁸Ga-DOTA-TOC-PET/CT detects heart metastases from ileal neuroendocrine tumors.

Authors:  Jan Calissendorff; Anders Sundin; Henrik Falhammar
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

3.  Incidental Finding of a Large Right Atrial Thrombus in a Patient With Cerebral Lymphoma.

Authors:  Ayman R Fath; Abdullah S Eldaly; Amro Aglan; Kyle S Varkoly; Roxana N Beladi; Anup Solsi; Mary F Hahn; John P Karis; Sina Nafisi; Kevin Brady; Pallavi Bellamkonda; Dara N Wakefield; William L Clapp; Alexandra R Lucas
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.